Clinical trial
Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and…
NCT00097071 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00097071 |
|---|---|
| Title | Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents |
| Official title | Safety and Efficacy of Insulin Aspart Versus Insulin Lispro in Insulin Pumps in Children and Adolescents With Type 1 Diabetes |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | insulin lispro, insulin aspart |
| Enrollment | 299 |
| Start date | Oct 1, 2004 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Nov 18, 2004 |
| Last update posted | Dec 22, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: